GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
Top Cited Papers
Open Access
Abstract
Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a central position in cell metabolism and signaling, with important roles both in physiological and pathological conditions. GSK-3 has been associated with a number of human disorders, such as neurodegenerative diseases including Alzheimer’s disease (AD). GSK-3 contributes to the hyperphosphorylation of tau protein, the main component of neurofibrillary tangles (NFTs), one of the hallmarks of AD. GSK-3 is further involved in the regulation of different neuronal processes that are dysregulated during AD pathogenesis, such as the generation of amyloid-β (Aβ) peptide or Aβ-induced cell death, axonal transport, cholinergic function, and adult neurogenesis or synaptic function. In this review, we will summarize recent data about GSK-3 involvement in these processes contributing to AD pathology, mostly focusing on the crucial interplay between GSK-3 and tau protein. We further discuss the current development of potential AD therapies targeting GSK-3 or GSK-3-phosphorylated tau.Keywords
This publication has 210 references indexed in Scilit:
- Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus SpecificityPLOS ONE, 2013
- Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cellsExperimental Cell Research, 2011
- Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed miceInternational Journal of Neuropsychopharmacology, 2011
- Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesiclesNature Neuroscience, 2010
- Blocked Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3α/β Impairs In Vivo Neural Precursor Cell ProliferationBiological Psychiatry, 2009
- Tau isoform regulation is region‐ and cell‐specific in mouse brainJournal of Comparative Neurology, 2008
- The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicityJournal of Neuroscience Research, 2008
- The role of GSK‐3 in synaptic plasticityBritish Journal of Pharmacology, 2008
- Role of GSK3β in behavioral abnormalities induced by serotonin deficiencyProceedings of the National Academy of Sciences, 2008
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004